Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04094532Completed
Randomised, double-blind trial of bupivacaine in acute pain and chest pain, sponsored by Atatürk University. Primary endpoint: Postoperative opioid consumption at 24 hours. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04094532.